THE ASSOCIATION BETWEEN ANTI-U1-RNP ANTIBODY AND MULTIORGAN DAMAGE IN SYSTEMIC LUPUS ERYTHEMATOSUS

Xuân Hương Vũ1,, Hữu Doanh Lê1,2, Thị Phượng Hoàng2, Thị Thu Hiền Đỗ1,2, Huy Lượng Vũ1,2
1 HMU
2 National Hospital of Dermatology and Venereology

Main Article Content

Abstract

Objective: To eValuate the association between anti U1-RNP antibody and some organ’s damage in systemic lupus erythematosus. Subjects and methods: A cross-sectional descriptiVe study was conducted on 48 systemic lupus erythematosus patients diagnosed according to the criteria of the Systemic Lupus. International Collaborating Clinics 2012 (SLICC 2012) at the National Hospital of Dermatology and Venereology from September 2021 to September 2022 and was tested to detect anti-U1- RNP antibodies in the blood using the ANA 23 profile test kit. Result: Among 48 patients participating in our study, up to 97.9% female patients. The mean age of onset was 31.6 ± 14.3 years old. The positiVe rate of anti U1-RNP antibody was 39.6% and mainly positiVe at strong leVel 3+ (47.4%). The rate of interstitial lung disease detected by high-resolution computed tomography was 39.5%, in which the anti- U1-RNP positiVe group was higher than the negatiVe group (p=0.028). The rate of increase in muscle enzymes (CK > 190 U/l) was 47.9%, in which the positiVe anti U1-RNP group (68.4%) was higher than


 


 


 


the negatiVe group (34.5%) (p=0.038). The rate of Raynaud's phenomenon in positiVe group (63.2%) was higher than the negatiVe group (17.2%) (p=0.001). Conclusion: Patients with systemic lupus erythematosus who were positiVe for anti U1-RNP had a higher risk of deVeloping lung damage, muscle damage and peripheral Vascular damage than the negatiVe group.

Article Details

References

1. Li M, Zhang W, Leng X, et al. Chinese SLE Treatment and Research group (CSTAR) registry:
I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus. Lupus. 2013;22(11):1192-1199. doi:10.1177/0961203313499086
2. Trần Hậu Khang (2011). Nghiên cứu tình hình, đặc điểm bệnh lupus ban đỏ tại bệnh Viện Da liễu Trung ương. Tạp chí Y học Việt Nam, Hà Nội.:49-53.
3. Nguyễn Thị Hà Vinh (2014). Mối liên quan giữa kháng thể kháng Ro/SSA Và biểu hiện lâm sàng, cận lâm sàng của bệnh nhân lupus ban đỏ hệ thống. Luận văn Thạc sĩ Y học chuyên ngành Da liễu, Trường Đại học Y Hà Nội, Hà Nội.
4. Wang CL, Ooi L, Wang F. PreValence and clinical significance of antibodies to ribonucleoproteins in systemic lupus erythematosus in Malaysia. Br J Rheumatol. 1996;35(2):129-132. doi:10.1093/rheumatology/35.2.129
5. Dima A, Jurcut C, Baicus C. The impact of anti- U1-RNP positiVity: systemic lupus erythematosus Versus mixed connectiVe tissue disease.



Rheumatol Int. 2018;38(7):1169-1178. doi:10.1007/s00296-018-4059-4
6. Faria AC, Barcellos KSA, Andrade LEC. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus. J Rheumatol. 2005;32(7):1267-1272.
7. Lê Huyền My (2018). Nghiên cứu một số tự kháng thể Và mối tương quan với tổn thương da trên bệnh nhân lupus ban đỏ hệ thống. Luận văn

Tiến sĩ Y học chuyên ngành Da liễu, Trường Đại học Y Hà Nội, Hà Nội.
8. Tang X, Huang Y, Deng W, Tang L, Weng W, Zhang X. Clinical and Serologic Correlations and Autoantibody Clusters in Systemic Lupus Erythematosus: A RetrospectiVe ReView of 917 Patients in South China. Medicine. 2010;89(1):62- 67. doi:10.1097/MD.0b013e3181cb449c.